Neurogene Inc. (NGNE) stock
NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$23.14+0.04 (+0.17%)
Close on Nov 18, 2026Market cap $463.06MP/E –Yield –
Neurogene operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Neurogene's operating cash flow for the twelve months ending Jun 30, 2026 was -$86.82M. For fiscal 2025 it was -$77.17M. The highest annual figure on record is -$7.23M in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$77.17M | – |
| FY2024 | Dec 31, 2024 | -$70.60M | – |
| FY2023 | Dec 31, 2023 | -$51.42M | – |
| FY2022 | Dec 31, 2022 | -$52.82M | – |
| FY2021 | Dec 31, 2021 | -$47.56M | – |
| FY2020 | Dec 31, 2020 | -$24.58M | – |
| FY2019 | Dec 31, 2019 | -$15.39M | – |
| FY2018 | Dec 31, 2018 | -$31.58M | – |
| FY2017 | Dec 31, 2017 | -$44.72M | – |
| FY2016 | Dec 31, 2016 | -$30.23M | – |
| FY2015 | Dec 31, 2015 | -$20.27M | – |
| FY2014 | Dec 31, 2014 | -$17.49M | – |
| FY2013 | Dec 31, 2013 | -$7.82M | – |
| FY2012 | Dec 31, 2012 | -$7.23M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$23.76M | – |
| Q1 FY2026 | Mar 31, 2026 | -$26.12M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.43M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.51M | – |
| Q2 FY2025 | Jun 30, 2025 | -$19.46M | – |
| Q1 FY2025 | Mar 31, 2025 | -$20.77M | – |
| Q4 FY2024 | Dec 31, 2024 | -$17.50M | – |
| Q3 FY2024 | Sep 30, 2024 | -$15.56M | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.89M | – |
| Q1 FY2024 | Mar 31, 2024 | -$21.65M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.97M | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.57M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.33M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.56M | – |
| Q4 FY2022 | Dec 31, 2022 | -$18.15M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.29M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.29M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.09M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.17M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.76M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.28M | – |
| Q1 FY2021 | Mar 31, 2021 | -$13.36M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.23M | – |
| Q3 FY2020 | Sep 30, 2020 | -$112.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.79M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.44M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.64M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.53M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.47M | -116.0% |
| Q1 FY2019 | Mar 31, 2019 | -$2.76M | – |
| Q4 FY2018 | Dec 31, 2018 | -$9.78M | – |
| Q3 FY2018 | Sep 30, 2018 | -$15.39M | – |
| Q2 FY2018 | Jun 30, 2018 | $9.18M | – |
| Q1 FY2018 | Mar 31, 2018 | -$15.59M | – |
| Q4 FY2017 | Dec 31, 2017 | -$11.61M | – |
| Q3 FY2017 | Sep 30, 2017 | -$11.53M | – |
| Q2 FY2017 | Jun 30, 2017 | -$10.30M | – |
| Q1 FY2017 | Mar 31, 2017 | -$11.28M | – |
| Q4 FY2016 | Dec 31, 2016 | -$9.00M | – |
| Q3 FY2016 | Sep 30, 2016 | -$7.44M | – |
See a number that looks wrong?